150 related articles for article (PubMed ID: 37296909)
1. Lymph Node Ratio Predicts Recurrence in Patients with Papillary Thyroid Carcinoma with Low Lymph Node Yield.
Kang IK; Park J; Bae JS; Kim JS; Kim K
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296909
[TBL] [Abstract][Full Text] [Related]
2. Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.
Rubinstein JC; Dinauer C; Herrick-Reynolds K; Morotti R; Callender GG; Christison-Lagay ER
J Pediatr Surg; 2019 Jan; 54(1):129-132. PubMed ID: 30361076
[TBL] [Abstract][Full Text] [Related]
3. Number of Metastatic Lymph Nodes and Ratio of Metastatic Lymph Nodes to Total Number of Retrieved Lymph Nodes Are Risk Factors for Recurrence in Patients With Clinically Node Negative Papillary Thyroid Carcinoma.
Zheng CM; Ji YB; Song CM; Ge MH; Tae K
Clin Exp Otorhinolaryngol; 2018 Mar; 11(1):58-64. PubMed ID: 29032663
[TBL] [Abstract][Full Text] [Related]
4. Central Lymph Node Ratio Predicts Recurrence in Patients with N1b Papillary Thyroid Carcinoma.
Kang IK; Kim K; Park J; Bae JS; Kim JS
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954338
[TBL] [Abstract][Full Text] [Related]
5. Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer.
Lee SG; Ho J; Choi JB; Kim TH; Kim MJ; Ban EJ; Lee CR; Kang SW; Jeong JJ; Nam KH; Jung SG; Jo YS; Lee J; Chung WY
Medicine (Baltimore); 2016 Feb; 95(5):e2692. PubMed ID: 26844509
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma.
Vas Nunes JH; Clark JR; Gao K; Chua E; Campbell P; Niles N; Gargya A; Elliott MS
Thyroid; 2013 Jul; 23(7):811-6. PubMed ID: 23373961
[TBL] [Abstract][Full Text] [Related]
7. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.
Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH
J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863
[TBL] [Abstract][Full Text] [Related]
8. Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.
Chang YW; Kim HS; Jung SP; Kim HY; Lee JB; Bae JW; Son GS
Int J Clin Oncol; 2016 Oct; 21(5):862-868. PubMed ID: 26837274
[TBL] [Abstract][Full Text] [Related]
9. Assessing the role of central lymph node ratio in predicting recurrence in N1a low-to-intermediate risk papillary thyroid carcinoma.
Ma T; Cui J; Shi P; Liang M; Song W; Zhang X; Wang L; Shi Y
Front Endocrinol (Lausanne); 2023; 14():1158826. PubMed ID: 37790606
[TBL] [Abstract][Full Text] [Related]
10. Lymph node ratio is superior to AJCC N stage for predicting recurrence in papillary thyroid carcinoma.
Parvathareddy SK; Siraj AK; Qadri Z; Ahmed SO; DeVera F; Al-Sobhi S; Al-Dayel F; Al-Kuraya KS
Endocr Connect; 2022 Feb; 11(2):. PubMed ID: 35044932
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of the Lymph Node Ratio of the Second Operation to Predict Re-Recurrence in Thyroid Carcinoma.
Park J; Kang IK; Bae JS; Kim JS; Kim K
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765580
[TBL] [Abstract][Full Text] [Related]
12. Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution.
Kim H; Kim K; Bae JS; Kim JS
Sci Rep; 2022 Aug; 12(1):13548. PubMed ID: 35941209
[TBL] [Abstract][Full Text] [Related]
13. PROGNOSTIC VALUE OF LYMPH NODE UPTAKE ON PRETREATMENT F-18 FDG PET/CT IN PATIENTS WITH N1B PAPILLARY THYROID CARCINOMA.
Lee CH; Lee SW; Son SH; Hong CM; Jeong JH; Jeong SY; Ahn BC; Lee J
Endocr Pract; 2019 Aug; 25(8):787-793. PubMed ID: 31013158
[No Abstract] [Full Text] [Related]
14. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
Ryu IS; Song CI; Choi SH; Roh JL; Nam SY; Kim SY
Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096
[TBL] [Abstract][Full Text] [Related]
15. Significance of micrometastases in the calculation of the lymph node ratio for papillary thyroid cancer.
Chang YW; Kim HS; Jung SP; Kim HY; Lee JB; Bae JW; Son GS
Ann Surg Treat Res; 2017 Mar; 92(3):117-122. PubMed ID: 28289664
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for level V metastasis in patients with N1b papillary thyroid cancer.
Kang JG; Choi JE; Kang SH
World J Surg Oncol; 2022 Sep; 20(1):327. PubMed ID: 36180912
[TBL] [Abstract][Full Text] [Related]
17. Lymph node ratio predicts recurrence in papillary thyroid cancer.
Schneider DF; Mazeh H; Chen H; Sippel RS
Oncologist; 2013; 18(2):157-62. PubMed ID: 23345543
[TBL] [Abstract][Full Text] [Related]
18. Impact of lymph node ratio on survival in papillary thyroid cancer.
Schneider DF; Chen H; Sippel RS
Ann Surg Oncol; 2013 Jun; 20(6):1906-11. PubMed ID: 23263904
[TBL] [Abstract][Full Text] [Related]
19. How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence.
Weitzman RE; Justicz NS; Kamani D; Kyriazidis N; Chen MH; Randolph GW
Laryngoscope; 2022 Sep; 132(9):1883-1887. PubMed ID: 35229306
[TBL] [Abstract][Full Text] [Related]
20. Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size.
Kim HI; Kim TH; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Jang HW; Kim YN; Kim H; Ahn HS; Kim K; Kim SW; Chung JH
Cancer Med; 2017 Oct; 6(10):2244-2251. PubMed ID: 28857489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
